We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+3.32%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.3B
AUM Growth
+$177M
Cap. Flow
+$235M
Cap. Flow %
18.05%
Top 10 Hldgs %
40.67%
Holding
213
New
103
Increased
34
Reduced
21
Closed
43

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$47.9M
2
ABBV icon
AbbVie
ABBV
+$27.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$18.7M
4
LPSN icon
LivePerson
LPSN
+$16.1M
5
AZN icon
AstraZeneca
AZN
+$13.6M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$40.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$26.4M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$12.8M
4
ZYME icon
Zymeworks
ZYME
+$11.6M
5
META icon
Meta Platforms (Facebook)
META
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 62.55%
2 Technology 7.69%
3 Industrials 4.91%
4 Financials 2.93%
5 Consumer Discretionary 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBTG icon
126
American Express Global Business Travel
GBTG
$4.93B
$1.49M 0.11%
+150,000
New +$1.57M
LCAHU
127
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
$1.49M 0.11%
+150,000
New +$1.49M
FMIVU
128
DELISTED
Forum Merger IV Corporation Unit
FMIVU
$1.49M 0.11%
+150,000
New +$1.49M
TWNI.U
129
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
$1.48M 0.11%
+150,000
New +$1.51M
KURIU
130
DELISTED
Alkuri Global Acquisition Corp Unit
KURIU
$1.48M 0.11%
+150,000
New +$1.53M
BBIO icon
131
BridgeBio Pharma
BBIO
$15.7B
$1.47M 0.11%
23,890
-134,010
-85% -$8.77M
LRMR icon
132
Larimar Therapeutics
LRMR
$397M
$1.46M 0.11%
+100,000
New +$1.82M
GMDA
133
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$1.44M 0.11%
178,450
+138,450
+346% +$1.27M
PMVP icon
134
PMV Pharmaceuticals
PMVP
$59.2M
$1.43M 0.11%
+43,356
New +$1.71M
FLAC
135
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$1.26M 0.1%
+126,687
New +$1.29M
VRTX icon
136
Vertex Pharmaceuticals
VRTX
$121B
$1.19M 0.09%
+5,530
New +$1.21M
LFTR
137
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
$1.18M 0.09%
+120,000
New +$1.26M
OBIO icon
138
Orchestra BioMed
OBIO
$238M
$1.12M 0.09%
100,000
– –
BGRY
139
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$1.11M 0.09%
+109,994
New +$1.19M
SWBK
140
DELISTED
Switchback II Corporation
SWBK
$1.02M 0.08%
+103,698
New +$1.06M
QSI icon
141
CALL
Quantum-Si Incorporated
QSI
$155M
$1.01M 0.08%
+85,000
New +$1.03M
FCAC
142
DELISTED
Falcon Capital Acquisition Corp. Class A Common Stock
FCAC
$997K 0.08%
+100,010
New +$1.09M
MACQU
143
DELISTED
MCAP Acquisition Corporation Unit
MACQU
$995K 0.08%
+100,000
New +$996K
OMEG
144
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$990K 0.08%
+100,000
New +$1.04M
VPCC.U
145
DELISTED
VPC Impact Acquisition Holdings III, Inc. Units, each consisting of one share of Class A common stoc
VPCC.U
$987K 0.08%
+100,000
New +$997K
VPCBU
146
DELISTED
VPC Impact Acquisition Holdings II Unit
VPCBU
$986K 0.08%
+100,000
New +$999K
ENFAU
147
DELISTED
890 5th Avenue Partners Inc Unit
ENFAU
$983K 0.08%
+98,828
New +$1.02M
MSPR
148
DELISTED
MSP Recovery Inc
MSPR
$982K 0.08%
+23
New +$1.03M
ETAC
149
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
$975K 0.07%
+100,000
New +$1.02M
CNTB
150
Connect Biopharma Holdings
CNTB
$127M
$925K 0.07%
+50,000
New +$851K
4 5
6
7 8

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2021 Portfolio in Review

As of Q1 2021, Sphera Funds Management held 213 positions worth $1.3B, up 16% from $1.13B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sphera Funds Management deployed $235M of net new capital in Q1 2021, opening 103 new positions and adding to 34 existing holdings. Its largest new stake was Sanofi: 997,900 shares worth $49.4M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 68% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $26.4M trimmed.

  • Sphera Funds Management's largest Q1 2021 buy was Sanofi: 997,900 shares worth $49.4M.
  • Sphera Funds Management added most to AbbVie in Q1 2021, an estimated $27.8M increase.
  • Sphera Funds Management's biggest Q1 2021 reduction was Bristol-Myers Squibb, cutting an estimated $26.4M.
  • Sphera Funds Management fully exited Novartis in Q1 2021, selling an estimated $40.5M.
  • Sphera Funds Management's ten largest holdings make up 41% of its $1.3B portfolio in Q1 2021.
  • Sphera Funds Management opened 103 new positions and closed 43 in Q1 2021.
  • Sphera Funds Management's portfolio value rose 16% quarter-over-quarter to $1.3B.

Based on Sphera Funds Management's 13F filing for Q1 2021, filed 17 May 2021.